Newsfeeds - Spark Newswire

2 minute read

FDA
News

Corcept Therapeutics Completes Enrollment In Phase 2 GRATITUDE Study Of Miricorilant In Patients With Antipsychotic-Induced Weight Gain

Today, 5:32 PM

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the

CORT

1 minute read

Earnings

Recap: Corcept Therapeutics Q4 Earnings

By Benzinga Insights

Today, 5:32 PM

Corcept Therapeutics (NASDAQ:CORT) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

CORT

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For February 2, 2022

By Benzinga Insights

Today, 5:32 PM

ABUS

13 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 28, 2022

By Benzinga Insights

Today, 5:32 PM

Upgrades

AAP

2 minute read

Corcept Therapeutics Reports Prelim. Results Of Previously-Announced Tender Offer For Up To 10M Shares Of Co. Stock Between $20.75-$23.75/Share In Cash

By Benzinga Newsdesk

Today, 5:32 PM

Corcept Therapeutics Incorporated (NASDAQ:CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by

CORT

2 minute read

News

Corcept Therapeutics Announces Waiver Of Condition To Its Tender Offer For Common Shares

By Benzinga Newsdesk

Today, 5:32 PM

Corcept Therapeutics Incorporated (NASDAQ:CORT) ("Corcept"), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by

CORT

2 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 5:32 PM

BFRI

4 minute read

52 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:32 PM

Gainers

AVCT

3 minute read

35 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 5:32 PM

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 79% to $18.63. Insignia Systems recently announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.

AVCT

1 minute read

Corcept Therapeutics Q3 Adj. EPS $0.30 Beats $0.20 Estimate, Sales $96.10M Miss $97.19M Estimate

By Benzinga Newsdesk

Today, 5:32 PM

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.20 by 50 percent. This is a 25 percent increase over earnings of $0.24 per share from the

CORT